COLL News and Press, Collegium Pharmaceutical Inc. From 10/25/20

Collegium Pharmaceuticals (NASDAQ: COLL) and Athenex (NASDAQ: ATNX) may not be the most popular stocks on the market in terms of media coverage, but both might just make you rich with a well-timed investment. Unlike many of their compatriots in the world of small market cap ...

STOUGHTON, Mass., Oct. 22, 2020 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL) announced today that the Company will host a conference call and live audio webcast on Thursday, November 5, 2020 at 4:30 p.m. Eastern Time. The Company will discuss its financial results a...

Catalyst Pharmaceuticals has dipped in recent months due to the lack of positive catalysts for the stock. This has brought renewed value to CPRX with Wall Street analysts predicting as much as 145% upside over the long term. Catalyst Pharma has reduced downside risks in comparison...

Collegium Pharmaceutical (COLL) has settled its patent infringement litigation with Teva Pharmaceutical Industries (TEVA) relate to the latter's U.S. marketing application seeking approval of a generic version of abuse-deterrent opioid pain med Xtampza ER (oxycodone).Under the terms of the ag...

STOUGHTON, Mass., Sept. 30, 2020 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a specialty pharmaceutical company committed to being the leader in responsible pain management, today announced that it has reached a settlement agreement with Teva Pharmaceutical USA, I...

STOUGHTON, Mass., Sept. 25, 2020 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a specialty pharmaceutical company committed to being the leader in responsible pain management, today announced the appointment of Rita Balice-Gordon to its Board of Directors, effective...

STOUGHTON, Mass., Sept. 14, 2020 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a specialty pharmaceutical company committed to being the leader in responsible pain management, today announced that five poster presentations highlighting data regarding its product por...

STOUGHTON, Mass., Sept. 09, 2020 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc.  (Nasdaq: COLL), a specialty pharmaceutical company committed to being the leader in responsible pain management, today announced that five poster presentations highlighting data regarding its product ...

Image source: The Motley Fool. Collegium Pharmaceutical Inc   (NASDAQ: COLL) Q2 2020 Earnings Call Aug 5, 2020 , 4:30 p.m. ET Operator Continue reading

Collegium Pharmaceutical, Inc. (COLL) Q2 2020 Earnings Conference Call August 05, 2020, 16:30 ET Company Participants Alex Dasalla - Head, IR Joseph Ciaffoni - President, CEO & Director Paul Brannelly - EVP & CFO Scott Dreyer - EVP & Chief Commercial Officer Conf...